We know very little about the microbiota inhabiting the upper female reproductive tract and how it impacts on fertility.
BACKGROUND
The vaginal microbiota has an established role in female reproductive tract physiology, pathogen defence, and function. 3 Longitudinal analysis subsequently showed that the vaginal microbiota is highly dynamic, with changes observed after sexual contact, menses, douching and lubricant use, 4 although, a separate study using CPN60 profiling reported community stability throughout the menstrual cycle. 5 There are few studies of the upper reproductive tract microbiota. Analysis of vaginal, cervical and endometrial specimens after insertion of an intrauterine levonorgestrel system (LNG IUS)
found a microbiota shift toward Lactobacillus crispatus. 6 Speciesspecific polymerase chain reaction (PCR) analysis of hysterectomy samples demonstrated that the upper reproductive tract microbiota did not correlate with selected host inflammatory markers. 7 Upon examining the tip of the transfer catheter used for embryo transfer during in vitro fertilisation (IVF), 8 a lower relative abundance of Pseudomonas spp. and Flavobacterium spp. were present in women who proceeded to successful pregnancy. 8 The diversity of the vaginal microbiota in women undergoing IVF embryo transfer was higher for women who had a live birth from the cycle. 9 The presence of a non-Lactobacillus dominant microbiota in the endometrium correlated with IVF embryo transfer failure.
10
While these reports support that the reproductive tract microbiota impacts fertility and pregnancy outcomes, much remains to be tested, such as examining infertility or pregnancy outcomes in the context of specific taxa, species level analysis, or the community state types/profiles. In this pilot study, we sought to examine the possible association of the reproductive tract microbiota with women who have a current or recent past history of infertility.
MATERIALS AND METHODS

Study design
We designed a pilot case-control study of the reproductive tract microbiota of women with a recent previous or current history of infertility (Cases), compared to women with no history of infertility (Controls) ( Table 1) . Women already undergoing hysteroscopy for a variety of reasons, excluding suspected cancer, were invited to participate. Participants categorised as Cases were currently attending gynaecological or fertility care, or attending for other gynaecological reasons but had a recent previous history of infertility that required assisted reproductive technologies. Inclusion criteria for Cases were women who had reported greater than a year of trying to achieve pregnancy, and who currently or previously required assisted reproductive technologies to achieve pregnancy. Five women in the infertile group were undergoing treatment for infertility at the time of recruitment; the remaining ten were having treatment for other gynaecological reasons, having previously required assisted reproductive technologies to achieve pregnancy. Given the retrospective and pilot nature of this study, type of infertility was not an inclusion or exclusion criteria. Participants recruited to the Control group were women who had a history of pregnancies with no need for assisted reproductive technologies, and who were attending gynaecological care for a hysteroscopy procedure (hysteroscopy for an intrauterine device (IUS) change, or hysterectomy, excluding suspected reproductive cancers). Gynaecological and obstetric histories were collected using a self-completed questionnaire. Several participants who were recruited and consented to the study, but were 50 years or over, were used for extraction method validation and were not included in the analysis. Participants whose vaginal and/or other specimens did not pass extraction quality assessment were not included for sequencing.
At the time of hysteroscopy in the operating theatre, a sterile speculum was inserted into the vagina, and swabs collected from the posterior fornix and the endocervical canal. The vagina was then prepared for surgery with betadine antiseptic surgical
solution. An endometrial biopsy was collected using an endometrial curette and stored in 0. 
Ethics approval and consent to participate
Availability of data and material
The dataset is available in sequence read archive (SRA) database under accession number: PRJEB18626.
Microbiota processing, amplification and analysis
The protocols for sample processing, 16S rRNA gene amplification, sequencing, statistical analysis of microbiota data, PCR for Ureaplasma, and quantitative PCR (qPCR) for endometrial gene expression are provided as Material S1.
Statistical analysis
To identify differences between cases and controls, we performed a non-parametric t-test using species level classifications, 11 fully described in Material S1. Plots were generated using the R Package Phyloseq v1.12.2. 12 We compared the proportions or distributions of the demographic (age), obstetric and gynaecological factors between the case and control groups using SPSS (specific test indicated with the results).
RESULTS
Case-control groups were comparable for gynaecological factors
This was a retrospective pilot case-control examination of the reproductive tract microbiota for women with a current or past history of infertility needing assisted reproductive technologies to conceive (Cases), compared to women with no history of infertility (Controls) ( Table 1) . The groups had similar proportions of the types of contraceptives in use, endometriosis and miscarriage (Table 1) . However, the number of live births, seeking pregnancy and age, were significantly different between the Cases and Controls.
Endometrial microbiota was generally lower in relative abundance
16S rRNA gene amplicon sequencing was performed on DNA isolated from the vagina, cervix and endometrium, for samples where this could be successfully extracted (summarised in Table S2 ). The sequence depth per sample was variable, with the highest number of filtered sequences obtained from vaginal (mean = 88 302) and cervical (mean = 95 401) samples (Table S2) . Endometrial samples produced fewer reads (average of 7815 per sample).
The genus Lactobacillus was most frequently observed (Fig. 1) .
The most abundant taxonomic units were the same in both cervical and vaginal specimens for all 24 of the 33 women where both were sequenced (Fig. 1 ). In women with sequences from both the endometrium and vagina, half had some differences in the proportions of the most abundant taxa relative to the vagina. A principal coordinates analysis of the Jensen-Shannon Divergence showed no grouping of specimens by reproductive site, age, casecontrol status (Fig. S1) . Similarly, Alpha Diversity analysis showed a variety of richness across the sites and case-control status with no clear associations (Fig. S1 ).
Community clusters were analysed using a cluster dendrogram 3 that is based on dominant or absent Lactobacillus species (Fig. 2) . Microbiota profiles were distributed across these 
Taxa over-represented in women with a history of infertility
We observed a trend for two organisms to be more abundant or prevalent in the Cases (Ureaplasma spp., P = 0.042 (vagina) 
Endometrial gene expression correlated with gynecological factors
We next assessed endometrial expression of selected genes with known endometrial function (interleukin (IL)-1α, IL-6, IL-8,
Tenascin-C (TN-C), tumour necrosis factor (TNF)α and Syndecan
(SDC1)
). There were no significant differences in the expression of these genes in relation to case-control status (Fig. 3a, b) . High expression of TN-C grouped in two clusters on a linkage dendrogram and was higher in women with a history of miscarriage (P < 0.001, Fig. 3c ). IL-6 expression levels were higher in LNG IUS users (P = 0.05), whereas SDC1 was significantly lower in LNG IUS users compared to oral contraceptive users (P < 0.01, Fig. 3d ).
F I G U R E 1
The relative proportion of the 25 most abundant taxonomic assignments. The key is to the right. The results are grouped according to the participants' Case-Control status (indicated at the top). The participant codes are below the graphs with each of the three specimen sites shown by row (indicated to the right: Vagina, Cervix, Endometrium). Only samples with more than 1000 assembled and assigned sequences are displayed.
Case Control
DISCUSSION
The objective of this pilot study was to examine the reproductive tract microbiota (vagina, cervix and endometrium) in women with a history of needing fertility treatment for pregnancy compared to fertile controls. We observed some differences in the upper reproductive tract (endometrium) compared to the vagina and cervix within individual participants. Furthermore, we showed a trend of Gardnerella in the cervix and Ureaplasma in the vagina being associated with women with a history of infertility, adding further support to the case that the microbiota should be further evaluated for relevance to fertility and assisted reproductive treatment.
Our study has a number of limitations that should be considered when interpreting these results. The time of fertility status is in the past, meaning the samples were not collected when the women were experiencing infertility/fertility. Also, the Control group was significantly older. Although three reproductive sites were sampled from each participant, inconsistencies in DNA ex- outcomes. 21 Here we provide a further association of Ureaplasma with infertility. The different abundance and presence/absence of taxa between the upper and lower genital tract specimens warrant further investigation, and our pilot study provides further baseline data to support the need for continued investigation into the endometrial microbiota. We speculate that the microbiome of the endometrium could be an important factor in unexplained infertility and/or repeat IVF cycle failures.
There were no differences in endometrial gene expression of our selection of target genes based on case-control (fertility)
status. TN-C had significantly high expression in participants with history of miscarriage, consistent with prior reports of an association with recurrent miscarriage. [22] [23] [24] [25] We also detected the expected differences in IL-6 endometrial gene expression in women using LNG IUS compared to other contraceptives, as this has been previously reported. 26, 27 SDC1 has been reported as a marker of endometritis, 28, 29 and here we found that SDC1 was significantly downregulated in LNG IUS users.
Our pilot study supports that the endometrium microbiota is likely to have subtle yet important differences from the lower 
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